Liquidia Corp announces that the United States Court of Appeals affirmed the earlier decision of the PTAB regarding the invalidity of a patent, allowing the company to pursue final regulatory approval of YUTREPIA by the FDA.
AI Assistant
LIQUIDIA CORP
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.